Cuproptosis: Revolutionizing Cancer Treatment with Copper's Hidden Potential.

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Copper is vital for biological functions but requires strict regulation.
• Cuproptosis is a newly identified regulated cell death pathway.
• This pathway results from excessive intracellular copper accumulation.

Purpose of the Study:

• To explore the mechanisms of cuproptosis.
• To investigate copper's role in malignancies.
• To advance targeted cancer therapies using cuproptosis.

Main Methods:

• Literature review on cuproptosis mechanisms.
• Analysis of copper's involvement in cancer.
• Discussion of therapeutic potential.

Main Results:

• Cuproptosis is initiated by copper binding to lipoylated enzymes in the TCA cycle.
• This binding causes enzyme aggregation, proteotoxic stress, and cell death.
• Copper-based treatments demonstrate potential in suppressing tumor growth.

Conclusions:

• Cuproptosis presents a unique mechanism for targeted cancer therapy.
• Copper-based strategies may overcome resistance to conventional chemotherapy.
• Further research is needed to develop novel anticancer agents targeting cuproptosis.